Version 2.77

Term Description

Noninvasive prenatal testing for risk of fetal aneuploidy (e.g. trisomy 21, XXY, etc.) is performed using maternal plasma (or serum) which contains circulating cell free (ccf) DNA from the fetus. The probability and result interpretation (high risk/low risk) of aneuploidy are based on dosage ccf DNA from the mother and fetus as well as the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of trisomy 13, 18 and 21 as well as fetal sex chromosome aneuploidy in women with singleton pregnancies of at least 10 weeks gestational age.
Source: Regenstrief LOINC

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
73967-2 Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
Indent73969-8 Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA R {risk}
Indent73824-5 Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Indent73968-0 Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA R {risk}
Indent73825-2 Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Indent73970-6 Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA R {risk}
Indent73966-4 Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Indent88572-3 Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Indent88571-5 Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Indent73821-1 Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA O {risk}
Indent73822-9 Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal O
Indent75693-2 Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA

Fully-Specified Name

Component
Noninvasive prenatal fetal aneuploidy panel
Property
-
Time
Pt
System
Plas.cfDNA
Scale
-
Method

Additional Names

Short Name
NIP fet aneu Pnl Plas.cfDNA
Display Name
Noninvasive prenatal fetal aneuploidy panel (cfDNA)
Consumer Name Alpha Get Info
Fetal Noninvasive prenatal fetal aneuploidy panel

Basic Attributes

Class
PANEL.MOLPATH
Type
Laboratory
First Released
Version 2.44
Last Updated
Version 2.73
Change Reason
Release 2.70: COMPONENT: Removed "test" from Component name for consistency across similar terms.; Previous Releases: The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Panel de prueba de aneuploidía fetal prenatal no invasiva:-:Punto temporal:ADN libre de células plasmáticas:-:
es-ES Spanish (Spain) Panel de test no invasivos para la detección prenatal fetal de aneuploidías:Propiedades mixtas (sólo paneles):Punto temporal:ADN en plasma libre de células:-:
fr-FR French (France) Aneuploïdie foetale prénatale non invasive test panel:-:Ponctuel:Plasma avec ADN libre circulant:-:
it-IT Italian (Italy) Microdelezione e aneuploidia fetale prenatale non invasiva, test panel:-:Pt:Plasma.DNA libero circolante:-:
Synonyms: DNA libero circolante nel plasma Panel test di microdelezione e aneuploidia fetale prenatale non invasiva Patologia molecolare Plasma Punto nel tempo (episodio) Set di prescrizione patologia molecolare
pt-BR Portuguese (Brazil) Teste pré natal aneuploidia fetal painel::Pt:Soro/Plas maternal^feto:-:
zh-CN Chinese (China) 无创性产前胎儿非整倍体性试验组套:-:时间点:血浆.cfDNA:-:
Synonyms: 分子病理学;分子病理学试验 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.分子病理学;分子病理学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;分子病理学医嘱组类;医嘱组类.分子病理学;实验室医嘱组类.分子病理学 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 无创性（无创型、无创、非侵入性）产前胎儿非整倍体性（非整倍体型、非整倍体、异倍体、非整倍性、异倍性、非整倍态、异倍体性）试验（检测、测试、检验项目、检查项目）组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目） 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套 血浆循环 cfDNA;血浆循环 DNA;循环游离核酸;血浆游离 DNA;血浆无细胞 DNA;Free circulating/Cell-free DNA;Free circulating DNA

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=73967-2
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/73967-2